Phase 3 Trials

Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will normally proceed through all four phases over many years. If the drug successfully passes through Phases 1, 2, and 3, it will usually be approved by the national regulatory authority for use in the general population.

  • Phase 1: Screening for safety
  • Phase 2: Establishing the testing protocol
  • Phase 3: Final testing
  • Phase IV: ‘Post-approval’ studies

In Phase 3 trials, the experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug or treatment to be used safely.


“Text is available under the Creative Commons Attribution-ShareAlike License Wikipedia.  Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization”.


Was this helpful to you?

GD Star Rating

Share this with your friends

Show your support